Hodgkin Disease

Hodgkin disease is a cancer of the lymphatic system that results from abnormal growth of cells in the lymphatic system. These cells can spread to other parts of the body. It can affect people of any age, but it is most common in people between the ages of 20 and 40 and over the age of 55.

Showing 1–12 of 14 results

Filter our product list:

Product Batch	Antigen	Molecular Class	Drug Brand	Product Concentration	CoA	Quantity per vial	Storage Temperature	Expiry Date	Price from
Brentuximab Vedotin 12710715	CD30	Antibody-drug conjugate (ADC)	Adcetris®	5 mg/mL	–	2 mg	-80°C	2027.09	997,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab 8038581	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	2025.05	316,00 €	view product Max: 2 Min: 1 Step: 1
Nivolumab 8039750	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	2025.03	316,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAN6970	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	2018.08	316,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAP6351	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	2018.10	316,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAQ3795	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	2018.02	316,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAU3964	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	2019.05	316,00 €	view product Max: 5 Min: 1 Step: 1
Nivolumab AAW0883	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	2019.01	316,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAW6409	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	2020.09	316,00 €	view product Max: 5 Min: 1 Step: 1
Nivolumab AAX0742	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	2020.11	316,00 €	view product Max: 7 Min: 1 Step: 1
Pembrolizumab 6302603D04	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	2018.07	528,00 €	view product Max: 7 Min: 1 Step: 1
Pembrolizumab 7302601E01	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	2018.12	528,00 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 7302607002	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	2019.03	528,00 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 7302613A05	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	2019.07	528,00 €	view product Max: 10 Min: 1 Step: 1

Not looking for Hodgkin Disease?

Search our therapeutic molecules product database